Original article
Bilateral Irreversible Severe Vision Loss From Cosmetic Iris Implants

https://doi.org/10.1016/j.ajo.2010.11.010Get rights and content

Purpose

To report a case of bilateral neovascular glaucoma with central retinal vein occlusions secondary to cosmetic iris implantation.

Design

Interventional case report.

Methods

setting: Tertiary care center; ophthalmology clinic. patient: A 25-year-old woman presented with persistent bilateral blurry vision after simultaneous bilateral cosmetic iris implantation. Examination showed best-corrected visual acuity of hand motion in the right and 20/400 in the left eye with intraocular pressures (IOP) of 48 mm Hg in the right and 40 mm Hg in the left eye on maximal medical therapy. She had bilateral neovascularization of the iris and angle with synechial angle closure, surgical aniridia, central retinal vein occlusion, and end-stage glaucomatous optic neuropathy. She was diagnosed with neovascular glaucoma in both eyes, associated with cosmetic iris implants. intervention procedures: Humphrey 24-2 visual field testing, optic nerve coherence tomography, and fundus imaging were performed. After bilateral intravitreal bevacizumab and panretinal photocoagulation, Ahmed glaucoma drainage devices were implanted in both eyes. main outcome measures: IOP, anterior chamber inflammation, neovascularization.

Results

Despite aggressive treatment, severe permanent bilateral vision loss ensued.

Conclusion

We strongly advise against the use of anterior chamber iris implants for cosmetic indications. Close monitoring of implanted individuals is necessary. Explantation should be considered at the earliest sign of adverse reaction.

Section snippets

Case Report

A 25-year-old Hispanic woman traveled to Panama and underwent simultaneous bilateral eye surgery to change the color of her irides with non-FDA-approved anterior chamber cosmetic iris diaphragm implants (NewColorIris) (Figure, Top row). Since the week following the surgery she complained of bilateral blurry vision, redness, tearing, and light sensitivity. Topical steroids for chronic iritis and IOP-lowering drops were prescribed by her surgeon during numerous postoperative visits back to

Discussion

This case highlights lessons learned from more than a half century of anterior segment implants, which appear to be simple procedures but may have complex, long-lasting, and deleterious effects. The first phakic intraocular lenses and prosthetic iris implantations were performed in the 1950s,5 but their use was associated with severe complications that included cataract formation, angle fibrosis, endothelial decompensation, and corectopia.6 There are 2 types of iris implants: iris diaphragm

Mathew K. George is a PGY-4 resident in Ophthalmology at Yale-New Haven Hospital, New Haven, Connecticut. He completed his medical school training at MS Ramaiah Medical College, Bangalore, India, and at Christian Medical College, Vellore, India prior to moving to the US for further research and training. He is currently applying for a clinical fellowship in medical retina.

Cited by (29)

  • Postoperative results of cosmetic iris implants

    2016, Journal of Cataract and Refractive Surgery
    Citation Excerpt :

    Additional data were requested from the author via e-mail, but no information was sent. Twenty-seven publications reporting complications were identified, including 20 articles in scientific journals,7–26 4 scientific meeting presentations,G–I,M and 3 videosJ–L (Table 1). The mean age of the patients in the reports was 32.6 years (range 19 to 65 years).

  • Prosthetic iris devices

    2014, Canadian Journal of Ophthalmology
    Citation Excerpt :

    We feel compelled to emphasize that this review does not address the NewColorIris, an implant that has been marketed for iris colour change in normal eyes. We are aware of no supportive reports in the world literature, although numerous authors have described severe ocular sequelae from their use.39–47 Operating on patients with congenital or traumatic aniridia often poses great challenges to the surgeons.

  • New color iris implants

    2012, Ophthalmology
View all citing articles on Scopus

Mathew K. George is a PGY-4 resident in Ophthalmology at Yale-New Haven Hospital, New Haven, Connecticut. He completed his medical school training at MS Ramaiah Medical College, Bangalore, India, and at Christian Medical College, Vellore, India prior to moving to the US for further research and training. He is currently applying for a clinical fellowship in medical retina.

View full text